National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Reference Center for Rare and Undiagnosed Diseases, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Front Public Health. 2023 Mar 2;11:1079601. doi: 10.3389/fpubh.2023.1079601. eCollection 2023.
Rare diseases (RD) are a health priority worldwide, overall affecting hundreds of millions of people globally. Early and accurate diagnosis is essential to support clinical care but remains challenging in many countries, especially the low- and medium-income ones. Hence, undiagnosed RD (URD) account for a significant portion of the overall RD burden.
In October 2020, the Developing Nations Working Group of the Undiagnosed Diseases Network International (DNWG-UDNI) launched a survey among its members, belonging to 20 countries across all continents, to map unmet needs and opportunities for patients with URD. The survey was based on questions with open answers and included eight different domains. Conflicting interpretations were resolved in contact with the partners involved.
All members responded to the survey. The results indicated that the scientific and medical centers make substantial efforts to respond to the unmet needs of patients. In most countries, there is a high awareness of RD issues. Scarcity of resources was highlighted as a major problem, leading to reduced availability of diagnostic expertise and research. Serious equity in accessibility to services were highlighted both within and between participating countries. Regulatory problems, including securing informed consent, difficulties in sending DNA to foreign laboratories, protection of intellectual property, and conflicts of interest on the part of service providers, remain issues of concern. Finally, most respondents stressed the need to strengthen international cooperation in terms of data sharing, clinical research, and diagnostic expertise for URD patients in low and medium income countries.
The survey highlighted that many countries experienced a discrepancy between the growing expertise and scientific value, the level of awareness and commitment on the part of relevant parties, and funding bodies. Country-tailored public health actions, including general syllabus of medical schools and of the education of other health professionals, are needed to reduce such gaps.
罕见病(RD)是全球卫生的重点,全球范围内影响着数亿人。早期和准确的诊断对于支持临床护理至关重要,但在许多国家,尤其是中低收入国家,这仍然具有挑战性。因此,未确诊的 RD(URD)占 RD 总负担的很大一部分。
2020 年 10 月,国际未确诊疾病网络发展中国家工作组(DNWG-UDNI)在其成员中发起了一项调查,这些成员来自各大洲的 20 个国家,旨在绘制 URD 患者的未满足需求和机会图。该调查基于开放式回答的问题,并包括八个不同的领域。有争议的解释在与相关合作伙伴联系后得到解决。
所有成员都对调查做出了回应。结果表明,科学和医疗中心为满足患者的未满足需求做出了巨大努力。在大多数国家,对 RD 问题的认识很高。资源匮乏是一个主要问题,导致诊断专业知识和研究的可用性降低。在参与国之间和内部,服务获取的公平性都存在严重问题。监管问题,包括确保知情同意、向外国实验室发送 DNA 的困难、知识产权保护以及服务提供者的利益冲突,仍然是令人关注的问题。最后,大多数受访者强调需要加强国际合作,以分享数据、开展临床研究以及为中低收入国家的 URD 患者提供诊断专业知识。
该调查强调,许多国家在不断增长的专业知识和科学价值、相关方和资助机构的意识和承诺水平之间存在差距。需要制定针对国情的公共卫生行动,包括医学院和其他卫生专业人员的普通教学大纲,以缩小这些差距。